IceCure Medical Ltd
NASDAQ: ICCM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Eyal Shamir
- Employees
- 64
- Headquarters
- Caesarea, Israel
- IPO year
- 2021
- Market cap
- $20.9M
- Website
- https://www.icecure-medical.com
Loading ICCM…
Loading profile data…Frequently asked questions about ICCM
What does IceCure Medical Ltd (ICCM) do?
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically f...
Where does ICCM trade?
IceCure Medical Ltd (ICCM) trades on the NASDAQ Capital Market.
What sector is ICCM in?
IceCure Medical Ltd (ICCM) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of IceCure Medical Ltd?
Eyal Shamir is the chief executive officer of IceCure Medical Ltd (ICCM).
Where is IceCure Medical Ltd headquartered?
IceCure Medical Ltd is headquartered in Israel.
Does ICCM pay a dividend?
IceCure Medical Ltd (ICCM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ICCM go public?
IceCure Medical Ltd (ICCM) completed its initial public offering in 2021.